The measure of impact: Proposal of quality metrics for solid organ transplant pharmacy practice.
Am J Transplant
; 24(2): 164-176, 2024 Feb.
Article
em En
| MEDLINE
| ID: mdl-37923084
ABSTRACT
As healthcare continues its transition toward value-based care, it is increasingly important for transplant pharmacists to demonstrate their impact on patient care, health-related outcomes, and healthcare costs. Evidence-based quality and performance metrics are recognized as crucial tools for measuring the value of service. Yet, there is a lack of well-developed and agreed-upon specific metrics for many clinical pharmacy specialties, including solid organ transplantation. To address this need, a panel of transplant pharmacy specialists conducted a detailed literature review and engaged in several panel discussions to identify quality metrics to be considered for assessing the value of clinical pharmacy services provided to solid organ transplant recipients and living donors. The proposed metrics are based on the Donabedian model and are categorized to coincide with the typical phases of transplant care. The measures focus on key issues that arise in transplant recipients related to medication therapy, including adverse drug events, nonadherence, and clinical outcomes attributable to medication therapy management. This article proposes a comprehensive set of measures, any number of which transplant pharmacists can adopt and measure over time to objectively gauge the value of services they are providing to transplant recipients, the transplant center, and the overall healthcare system.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Farmácia
/
Serviço de Farmácia Hospitalar
/
Transplante de Órgãos
/
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article